Cited by 72Acute Myeloid Leukemia ResearchHematopoietic Stem Cell TransplantationGenomics and Chromatin Dynamics

Is PU.1 a dosage-sensitive regulator of haemopoietic lineage commitment and leukaemogenesis?

Dakic, Aleksandar, Wu, Li, Nutt, Stephen L.·2007·Trends in Immunology

Abstract

The transcription factor PU.1 is an essential regulator of haemopoiesis and a suppressor of myeloid leukaemia. PU.1 displays a complex expression pattern characterized by high expression in myeloid cells and low amounts in lymphoid cells. Based on this transcriptional profile, and the analysis of cell lines and mice expressing altered levels of PU.1, a model has been proposed where the concentration of PU.1 determines cell fate, whereas the graded reduction, but not absence, of PU.1 facilitates leukaemogenesis. The recent reports of mouse strains that enable the accurate determination of PU.1 expression and the conditional inactivation of PU.1 in adult haemopoiesis have led us to re-examine our understanding of the complex functions of PU.1. Here, we will discuss the data that, we believe, argue against the dosage-sensitive model of PU.1-mediated lineage commitment and leukaemogenesis.

Integrity signals

Registry

Crossref · 10.1016/j.it.2007.01.006

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Dakic, A., Wu, L., & Nutt, S. L.
Affiliations
  • The University of Melbourne (AU)
  • Walter and Eliza Hall Institute of Medical Research (AU)
Corresponding author
Nutt, Stephen L.
Venue
Trends in Immunology
Publisher
Elsevier BV
Published
2007-03
Volume
28
Issue
3
Pages
108-114
ISSN
1471-4906 (ISSN-L)
OpenAlex
W1963771050
Cited by
72
References
16
Citations by year
2025: 4 · 2024: 2 · 2023: 2 · 2022: 2 · 2021: 3 · 2020: 2 · 2019: 2 · 2018: 4 · 2017: 3 · 2016: 5 · 2015: 4 · 2014: 3 · 2013: 4 · 2012: 10
FWCI
0.78
Type
journal article
Language
en
Open access
closed
Locations
  • Trends in Immunology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Pfizer Australia
  • National Health and Medical Research Council
  • Cancer Council Victoria
  • National Medical Research Council
Topics
  • Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
  • Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Keywords
PU.1, C/EBPβ, leukemogenesis, myeloid leukemia, hematopoiesis, transcription factor expression, myeloid cells, lymphoid cells
MeSH terms
Proto-Oncogene Protein Spi-1, Animals, Hematopoiesis, Humans, Leukemia, Proto-Oncogene Proteins, Trans-Activators, Cell Lineage, CCAAT-Enhancer-Binding Protein-alpha

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review